chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weakness of muscles; body aches; lethargy; headache; shivers; joint pain; muscular pain; This is a spontaneous report from a contactable consumer, the patient. A 25-years-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El3247) via an unspecified route of administration in left arm on 23Mar2021 at 09:30 (at the age of 25-years-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin since unknown date. The patient not had COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included fluticasone propionate (FLONASE) started from unknown date for unknown indication. Since the vaccination, the patient had not tested for COVID-19. Previously the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in left arm on an unknown date (also reported as 23Mar2021 at 09:00) as single dose for COVID-19 immunisation. On 23Mar2021 at 22:30, the patient experienced weakness of muscles, muscular pain, joint pain, body aches, headache, lethargy, shivers. The peak of these symptoms took place 14 hours after he got the shot. It persisted for 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the events. The clinical outcome of the events weakness of muscles, muscular pain, joint pain, body aches, headache, lethargy, shivers were resolved on 24Mar2021.   No follow-up attempts are needed. No further information is expected.
Pt's daughter called pharmacy to inform manager about adverse event. 40 mins following shot pt experienced excruciating pain. Was advised to ice area. 3 days later pain persists and worsening and radiating to neck. Pt cannot lift arm.
24 hours after flu injection felt tingling in lower lip, eyes felt swollen and hurt, nose congested. Mid throat irritation. No wheezing went to urgent care received steroid injection
Rash & fever started 4-18-12. TYLENOL & ibuprofen administered at home. Fussiness & fever prompted visit to clinic. Note states skin is pruritic with tiny bumps. Vesicles grouped; multiple papules & excoriation on trunk --> seen on 5-1-12.
pain; heart attack; couldn't talk, the pain was so hard; pain in his left arm; Indigestion; chest pain; small temperature that was one degree higher than before; wiped out tired-extremely exhausted and tired; This is a spontaneous report from a contactable consumer (patient's mother). A 20-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration, administered in right arm on 13May2021 at 11:00 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is very strict on his health. The patient is a vegetarian, he is very health conscious. The patient did not receive any other vaccinations within four weeks prior to the first administration of the COVID vaccine. The patient previously received the first dose of bnt162b2 on Apr2021 for COVID-19 immunization and experienced tenderness at the shot site and was very tired. On the morning of 14May2021, the patient had a small temperature that was one degree higher than before and the patient was wiped out tired-extremely exhausted and tired. Then the patient started experiencing chest pain within days of the second dose. The patient woke up on 15May2021 with chest pain that was persistent through 18May2021. On 19May2021, the chest pain got worse. The reporter thought the patient had indigestion so she gave the patient Tylenol, Pepcid, and clear soda and the patient felt a little better. On 20May2021, the patient was clutching his chest and had pain in his left arm. The patient couldn't talk, the pain was so hard. The patient went to the emergency room at 12:00 and the healthcare team said that the patient was experiencing a heart attack (reported time of heart attack was 10:00). The patient was not admitted to the hospital. They said the chemical that the large muscle in the heart makes, it was elevated which was how they determined it was a heart attack. These lab numbers were drawn every three hours and they came down but never went away. The patient had two Troponin draws and they were both elevated. They also did an EKG on the patient which showed a heart attack. The patient was told to see a cardiologist and was sent home. The reporter is watching the patient and the patient is still in a little bit of pain but not as much. The patient went to his primary care provider on the day of the report and the doctor doesn't see this as a displaced issue. The doctor does not know what would cause this in the heart. The patient is to see the cardiologist on Tuesday, 25May2021. The reporter is unsure if this is related to the vaccine but it was almost a week after the patient's second dose. The outcome of the event small temperature that was one degree higher than before was recovering and the outcome of the event wiped out tired-extremely exhausted and tired was not recovered. The outcome of the other events was unknown.   Information on the lot/batch number has been requested
3/25/2022 at 1317 Employee called the Nurse Vaccine Support line to report symptoms post COVID-19 booster vaccine. Vaccine Name - Pfizer Vaccine Date - 3/23/2022 Booster Dose - Yes Location - Right Deltoid Date of Symptom Onset - 3/24/2022  Symptoms - Severe Diarrhea, Numbness to Right Side of Face, Tingling & Itching of Tongue, Headache, Ear Pain, Fever (Tmax 100F) Last Day of Work and Shift - 3/23/2022 (830a - 5p) Home Remedies - Tylenol 500 mg Every 6 Hours through Present (Started on 3/23/2022 at 3p prior to injection per Transplant HCP instructions) Any Improvement - No
the PENTACEL dose was given yesterday 20Mar2023, but it expired on 25Feb2023 with no reported adverse event; Initial information received on 22-Mar-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 15 months old male patient and reporter reported the Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)]  dose was given yesterday 20mar2023, but it expired on 25feb2023 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 20-Mar-2023, the patient received 0.5 ml dose of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine Suspension for injection (Expiry date: 25-Feb-2023) (Frequency-Once) (Strength- Standard) (with an unknown lot number) via intramuscular route in the right thigh for Immunisation.  On 20-Mar-2023, the patient received Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine dose was given yesterday 20mar2023, but it expired on 25feb2023 with no reported adverse event (expired product administered) (Latency: same day).  It was reported, This situation is reported as a medication error due to patient receiving an expired dose of PENTACEL.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event the pentacel dose was given yesterday 20mar2023, but it expired on 25feb2023 with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
covid Vaccine was diluted with 1.4 ml instead of 1.8ml, at this time no adverse reaction. Provider called patient to let them know of the error and to call back if any reactions.
Slight ha when woke up on 16th. Within 15 min dizzy and passed out. Heavy vomiting and no strength. Bone crushing pain, Laid on floor, partner called 1-800 suggested pepto mismol. Vommitted that. Called EMS to help Get. Me to bathroom and back laid down. No fever. Took other vs . Next thing I know I was in bed eating toast and cola. Left me still weak and trouble keeping balane. Should I get 2nd shot?
Pfizer-BioNTech Covid 19 Vaccine EUA: One week post-injection I experienced extreme fatigue, body aches, chills, shivering, hot and cold flashes. At this time the symptoms have persisted for 30 hours, although the shivering subsided after sleeping through the night. The heavy fatigue and body aches continue however.
Narrative:  COVID infection following COVID vaccine series 04/06, Pfizer, dose #1 04/27, Pfizer, dose #2 06/11 COVID swab, result: not detected 08/07 pt cc: cough exposure: unknown 08/13 COVID swab, result: detected 09/07 pt admit with cc: Chest pain, DX: Musculoskeletal LOC 1 day 09/07 CXR impression: No acute cardiopulmonary process identified. 09/07 COVID-19 ANTIGEN(BINAX) result: not detected 09/07 TROPONIN I result: <0.016 09/07 EKG 12-lead NSR with no evidence acute ischemia.
Patient was observed for 30 minutes following her vaccine and then was dismissed of, symptom free. She then returned after 12 minutes complaining of feeling hot and flushed and throat, face and arms itching. Her O2 sat was 99% on  room air, heart rate 71, respiratory rate of 18. She was given Benadryl 50 mg PO and after 10 or 15 minutes stated she did not have any of noted symptoms any longer.
Information has been received from a healthcare professional concerning a 32 month old female who was vaccinated with a dose of haemophilus b conjugate vaccine and subsequently, the pt developed haemophilus type b infection despite vaccination and meningitis. The pt's haemophilus type b infection despite vaccination and meningitis, have been determined to be "Other Medical Events". The outcome of the pt's events was reported as unknown. No further information is available.
Patient was inadvertently given an adult dose of Hepatitis B instead of Pediatric dose of Hepatitis B. I realized after the patient left that this error was made.
Severe pain in right knee on Aug. 10th.  Blood pressure spiked found on Aug. 20th 165/110, my normal has always been 110/70.  Went to Dr. after feeling bad all week.  Aug. 11th began feeling off balance, and severe ringing in both ears with tightness in my head.  Ears felt plugged.  Heart racing,   This is continuing through today Aug. 24 2021.
Nasal congestion; Cough; tested positive for COVID-19; Sneezing; Runny nose; low grade fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for COVID-19), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), NASAL CONGESTION (Nasal congestion) and COUGH (Cough) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and PYREXIA (low grade fever). On 05-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19). On 09-Mar-2021, the patient experienced NASAL CONGESTION (Nasal congestion) and COUGH (Cough). At the time of the report, COVID-19 (tested positive for COVID-19), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), NASAL CONGESTION (Nasal congestion), COUGH (Cough) and PYREXIA (low grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.
Intense pain, on left arm (underarm, breast area)/ Intense lymph node pain on the axilla on the same side of injection; Intense swelling, on left arm (underarm, breast area)/ Intense lymph node swelling on the axilla on the same side of injection; Mild soreness on injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of LYMPH NODE PAIN (Intense pain, on left arm (underarm, breast area)/ Intense lymph node pain on the axilla on the same side of injection), LYMPHADENOPATHY (Intense swelling, on left arm (underarm, breast area)/ Intense lymph node swelling on the axilla on the same side of injection) and VACCINATION SITE PAIN (Mild soreness on injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (Mild soreness on injection site). On 25-Mar-2021, the patient experienced LYMPH NODE PAIN (Intense pain, on left arm (underarm, breast area)/ Intense lymph node pain on the axilla on the same side of injection) and LYMPHADENOPATHY (Intense swelling, on left arm (underarm, breast area)/ Intense lymph node swelling on the axilla on the same side of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Mar-2021, VACCINATION SITE PAIN (Mild soreness on injection site) had resolved. At the time of the report, LYMPH NODE PAIN (Intense pain, on left arm (underarm, breast area)/ Intense lymph node pain on the axilla on the same side of injection) and LYMPHADENOPATHY (Intense swelling, on left arm (underarm, breast area)/ Intense lymph node swelling on the axilla on the same side of injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Local injection: Pain-discomfort. General Symptoms: Chills, headaches, muscle pains, fatigue, nausea, vomiting.   Narrative:
Blood count was low; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD DISORDER (Blood count was low) in a 75-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: COVID-19 VACCINE. Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE.    In September 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD DISORDER (Blood count was low). At the time of the report, BLOOD DISORDER (Blood count was low) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Full blood count: Low.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.  Treatment medication not reported.   Reporter did not allow further contact
Confirmed no other AE occurred; An expired dose of MMRIII was administered; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.  The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 19-APR-2023, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot number w005208 has been determined to be valid for varicella virus vaccine live (oka/merck) (VARIVAX), expiration date reported and established as 14-FEB-2024), and on 20-APR-2023, the patient was vaccinated with the first dose of an expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (expired product administered) subcutaneous injection (lot number u007686 has been determined to be valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date reported and established as 09-MAR-2023), both administered for prophylaxis (strength,  dose, frequency and anatomical site of administration were not provided).
Information has been received from a nurse practitioner concerning a 12 years old female patient with no allergies and no medical history who on 24-APR-2007 was vaccinated with the first dose of GARDASIL (lot No. 653938/0954F) into the right deltoid and an unspecified dates was vaccinated with the second and the third dose of GARDASIL. Concomitant therapy included BACTRIM after the shot was given. Following the second dose of GARDASIL the patient developed a small lighter skin discoloration at the injection site. The patient sought medical attention, office visit. At the time of the reporting, the patient was recovering. The reporter also indicated the patient's twin sister had the same symptoms after receiving the second dose of GARDASIL. Follow up information was received reporting that at the time of vaccination the patient had bladder infection. On 11-DEC-2007 the patient experienced molluscum contagiosum. At the time of the reporting, the outcome was unknown. Additional information is not expected.
Cough; This is a spontaneous report from a contactable consumer (patient).  This is the 1st of 2 reports, for the 1st dose.  An 81 years old patient of unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, at age of 80 years old,  administered in Arm Left (upper) on 15Feb2021 (Lot Number: EL9267) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were none. The patient experienced cough in about 10 days from the time got the shot. The patient did not had cough before and did not have a cold. Cough medication for the cough took but it did not seem to be working good (Unspecified medication). Outcome of event was unknown.    No follow-up attempts are needed. No further information is expected. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021427456 Same patient, different dose and event.
While seated in observation area the patient developed a metalic taste in her mouth and became anxious. She felt like her heart rate was fast and she got dizzy. She stated some chest pressure 4/10 and shortness of breath.  She had no signs and symptoms of an allergic reaction. Assessment showed no angioedema, no hives, a radial pulse of 112 and regular, skin was pink, warm, and dry, respirations were non labored, no dyspnea was noted. She was alert and oriented at time of release.
blood pressure was elevated; Racing heartbeat- random and not steady; Dull and steady as well as Sharp pains- deep in left armpit; pains radiating out to shoulder and down toward chest; Stomach spasms throughout the day; swollen left armpit; Dull and steady as well as Sharp pains- deep in left armpit; pains radiating out to shoulder and down toward chest; Dull and steady as well as Sharp pains- deep in left armpit; pains radiating out to shoulder and down toward chest; This is a spontaneous report from a contactable consumer. This 52-year-old female consumer (patient) reported. A 52-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EW0150), dose 2 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:00 (at the age of 52-years-old) as a single dose for covid-19 immunization. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6204), dose 1 via an unspecified route of administration, administered in Arm Left on 18Mar2021 13:00 (at the age of 52-years-old) as a single dose for covid-19 immunization and experienced strong skin tingling all over my body; no fever; knee joints felt like they were on fire; fatigue; headache; a few heart palpitations- this was sporadic and did not last long; numbness of left side and marked numbness of left thumb and up left forearm- headache started immediately; all symptoms mostly gone within 3 days. The patient medical history was not reported. Concomitant medication(s) in two weeks included estradiol; lisinopril. The patient did not have any allergies. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 13:30, the patient experienced racing heartbeat- random and not steady; dull and steady as well as sharp pains- deep in left armpit; pains radiating out to shoulder and down toward chest; swollen left armpit. Stomach spasms throughout the day. Most symptoms started within 12 hours of shot. Within in about 24 hours, armpit pain has gone from dull and steady to sharp stabbing. Didn't want to move arm; called cardiologist's office and they told her to go to Emergency room. She went to the emergency room; blood pressure was elevated but testing showed she was not having a heart attack. Sent home. Still experiencing stomach spasms. Taking Mylanta for a few days to see if pain subsides. The patient underwent lab tests and procedures which included blood pressure measurement: elevated, heart rate: racing, investigation: not having a heart attack. The patient receive treatment for events arthralgia, chest pain, axillary pain and nothing for other events. Outcome of the event axillary pain was recovered, stomach spasms was not recovered and swollen left armpit, arthralgia, chest pain was recovering, at the time of this report. No follow-up attempts are possible. No further information is expected.
11/7/2020  after vaccine patient experience some pain in the arm with a slight headache about 4pm.  At 8:30 pm caller went to bed and callers husband  found caller to be confused with fever 107. Callers husband called ambulance and caller was taken hospital. O2 stats were 40 and blood sugar was 50.Caller stayed in hospital for 48 hours and was released on Tuesday.
Have regular periods and carefully track them as trying to conceive. Period is 4 days late (for first time in my life) after 2nd Covid vaccine. Unknown if / when my period will start again. Multiple negative pregnancy tests.
Extreme pain in right abdomen; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Extreme pain in right abdomen) and VOMITING (Vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced ABDOMINAL PAIN (Extreme pain in right abdomen) and VOMITING (Vomiting). At the time of the report, ABDOMINAL PAIN (Extreme pain in right abdomen) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.